亚裔美国人亚种群中的心力衰竭
Yan Cheng1,2, Adrienne N Poon3, Youxuan Ling1
1Department of Clinical Research and Leadership, George Washington University, Washington, DC.
JAMA network open
|September 26, 2024
概括
心力衰竭 (HF) 的发病率和患病率在亚裔美国人亚组之间有很大差异. 东南亚患者的HF发病率较高,与黑人患者相比,突出了需要进行种族特异性风险评估的需要.
科学领域:
- 心血管医学 心血管医学
- 公共卫生 公共卫生
- 健康差异 在健康上的差异
背景情况:
- 心力衰竭 (HF) 是美国死亡的主要原因.
- 关于亚裔美国人,特别是亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚裔亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚 亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚 亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚
研究的目的:
- 为了比较不同亚裔美国人亚组中心力衰竭 (HF) 的发生率和患病率.
- 为了识别种族和族裔群体之间HF结果的差异.
主要方法:
- 使用2015-2019年电子健康记录数据的回顾性队列研究.
- 包括来自美国100多个医疗保健系统的40岁或以上的患者.
- 使用ICD代码对HF发病率和流行率的分析,根据年龄和性别标准化.
主要成果:
- 在亚裔美国人亚组中观察到年龄和性别标准化HF发病率的显著差异.
- 与白人患者 (1.58%) 相比,东南亚患者的HF发病率较高 (2.26%),与黑人患者 (2.39%) 相似.
- 东亚 (1.22%) 和南亚 (1.56%) 患者也表现出明显的HF发病率,并指出异质的流行率.
结论:
- 亚裔美国人亚组之间存在HF结果的差异,东南亚人表现出与黑人患者相似的比例.
- 调查结果强调了在HF风险评估中考虑亚洲个体种族和特定心血管风险因素的重要性.
- 该研究强调,需要针对不同亚裔美国社区的定制公共卫生战略来应对高温风暴.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398
Heart Failure Drugs: β-Blockers
321
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
321
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Heart Failure Drugs: Diuretics
350
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
350


